BM 2 Consulting SRL

BM 2 Consulting reported revenue of 249,775 € for the 2025 financial year (annual accounts filed with the NBB on 13 Oct 2026).

Company number (CBE) 0742.799.571 · VAT BE0742799571
1654 Beersel
active in Wholesale of pharmaceutical and medical goods (NACE 46460)
operating since 31 Jan 2020 (≈ 6 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of BM 2 Consulting shows with a free account.

See the score
Profile
SRL since 2020
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Revenue249,775 €
Net result77,063 €
Equity145,097 €
Cash12,323 €
EBITDA88,020 €
Total assets207,573 €
Solvency69.9%
The line marks its sector median: 46.0% (567 companies).

Change 2022 → 2025: Revenue +39 % Equity +226 % Total assets +65 %

Accounts of the company itself (not consolidated).

The full file covers 6 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

BM 2 Consulting's annual accounts

20252024202320222021
Revenue249,775 €
Net result77,063 €
Equity145,097 €
Cash12,323 €
EBITDA88,020 €
Total assets207,573 €

Filed annual accounts

  • Year ended 31 Dec 2025filed on 13 Oct 2026
  • Year ended 31 Dec 2024filed on 27 Sep 2025
  • Year ended 31 Dec 2023filed on 30 Sep 2024
  • Year ended 31 Dec 2022filed on 29 Nov 2023
  • Year ended 31 Dec 2021filed on 14 Oct 2022

BM 2 Consulting's financial analysis

Management and control of BM 2 Consulting

1 active director(s) in the register.

BM 2 Consulting's shareholders and holdings →

BM 2 Consulting's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0742.799.571
VAT number
BE0742799571
Peppol
Registered · 0208:0742799571 · as of 10 Nov 2026
Legal form
SRL
Incorporated
31 Jan 2020
Registered office
1654 Beersel
Latest accounts
2025 · filed on 13 Oct 2026
Activity
Wholesale of pharmaceutical and medical goods (NACE 46460)

BM 2 Consulting (SRL) has been based in Beersel since 2020, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports revenue of 249,775 €, a net profit of 77,063 € and equity of 145,097 €. Its solvency stands at 69.9%, above the median of its sector (46.0%).

Companies similar to BM 2 Consulting

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about BM 2 Consulting

What is the revenue of BM 2 Consulting?

According to the 2025 annual accounts filed with the NBB, the revenue of BM 2 Consulting amounts to 249,775 €.

What is the VAT number of BM 2 Consulting?

In Belgium, the VAT number is the company number prefixed with BE: BE0742799571 for BM 2 Consulting, if the company is VAT-registered. Its company number (CBE) is 0742.799.571.

Where is the registered office of BM 2 Consulting?

According to the CBE register, the registered office of BM 2 Consulting is in 1654 Beersel.

What is the equity of BM 2 Consulting?

At the close of the 2025 financial year, the equity of BM 2 Consulting amounts to 145,097 €, a solvency of 69.9% of total assets.

Who manages BM 2 Consulting?

The register lists 1 active mandates at BM 2 Consulting. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of BM 2 Consulting

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 15 Oct 2026

No credit card, no commitment.

What each plan unlocks →